CLINICAL_TRIALS
research
· 2025-05-08
Clinical Trial Update: Outcomes of Arterial Allografts Preserved at +2 to +8°C for Revascularization in Septic Settings
Summary
An update on a clinical trial evaluating arterial allografts preserved at 2–8°C for revascularization in septic or potentially septic environments; the study is…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospices Civils de Lyon | Conditions: Revascularization in a Septic or Potentially Septic Environment | Status: ACTIVE_NOT_RECRUITING